SUMO2 and nasopharyngeal carcinoma: By binding directly to SUMO2’s 3 ‘- UTR, circRNF13 could upregulate its expression, promoting GLUT1 ubiquitination degradation, which, in turn, may inhibit the glycolytic pathway and ultimately suppress NPC proliferation and migration (Figure 6).